Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
It does not require reconstitution and uses a different dosing mechanism (drops or spray rather than syringe units)
In general, the longer-acting GLP-1 agonists which are injected weekly, such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro), are associated with greater weight loss than the shorter-acting GLP-1 agonists such as liraglutide (Saxenda)
The reduction in body weight achieved through GLP-1RA therapy holds significant implications beyond metabolic health
By the end of 2035, it is expected to surpass US$ 132.79 billion, growing steadily at a CAGR of 9.63%
When name-brand GLP-1s such as Wegovy first started being prescribed for weight loss, in 2021, they were inaccessible for most Americans because of their steep cost and insurance providers limited coverage
Overview of the Current Incretin Mimetic Landscape Brief History Brief History The first GLP-1 agonists were famously inspired by the venom of the Gila monster (a desert dwelling lizard)
US$ 26.11
US$ 23.75
US$ 23.56
US$ 27.06
US$ 21.85
US$ 25.23
US$ 20.22
US$ 25.53
US$ 29.29
US$ 29.73
US$ 22.48
